Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRT in Peri/Postmenopausal Women with SLE
NCT00392093Phase 4Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Nov 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of conjugated estrogens and medroxyprogesterone acetate in menopause and osteoporosis, sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoint: Global disease activity estimated as the area under the SLEDAI-curve at 24 months. Started Nov 1997; status: completed.
02
Drugs
conjugated estrogensmedroxyprogesterone acetate
03
Conditions
menopauseosteoporosis
Beyond the preview
Go deeper on NCT00392093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392093.